NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

現實世界證據 (RWE) 解決方案的全球市場:各零件 (資料集,電子健康記錄,服務)、各用途 (藥物開發、核准 (腫瘤,神經症,免疫疾病),到市場進入,醫療設備開發)、各終端用戶的未來預測 (2027年)

Real World Evidence (RWE) Solutions Market by Component [Datasets, EMR, Services], Application [Drug Development and Approvals (Oncology, Neurology, Immunology), Market Access, Medical Device Development], End User - Forecast to 2027

出版商 Meticulous Market Research Pvt. Ltd. 商品編碼 973572
出版日期 內容資訊 英文 194 Pages
訂單完成後即時交付
價格
現實世界證據 (RWE) 解決方案的全球市場:各零件 (資料集,電子健康記錄,服務)、各用途 (藥物開發、核准 (腫瘤,神經症,免疫疾病),到市場進入,醫療設備開發)、各終端用戶的未來預測 (2027年) Real World Evidence (RWE) Solutions Market by Component [Datasets, EMR, Services], Application [Drug Development and Approvals (Oncology, Neurology, Immunology), Market Access, Medical Device Development], End User - Forecast to 2027
出版日期: 2020年12月02日內容資訊: 英文 194 Pages
簡介

全球RWE解決方案市場,預計2020年∼2027年以16.5%的年複合成長率成長,2027年達到31億3000萬美元。各零件中資料集的領域,各用途中藥物開發、核準的領域成為最大的市場區隔。各地區中北美各國是世界最大的市場,其次依序是歐洲、亞太地區、南美、中東、非洲。

本報告提供全球現實世界證據 (RWE) 解決方案的市場相關分析,市場基本結構和主要的促進、阻礙因素,整體市場趨勢預測 (今後8年份),各零件、各用途、各終端用戶、各地區的詳細趨勢,近幾年的市場競爭、資本交易的動向,主要企業簡介等調查。

目錄

第1章 簡介

第2章 分析方法

第3章 摘要整理

第4章 市場考察

  • 簡介
  • 推動市場要素
    • 老年人的慢性病患的負擔增加
    • 藥物開發延遲,與伴隨的開發費增加
    • 對個人化醫療的關注增加
    • 轉移 "價值為基礎醫療"
    • COVID-19的影響評估
    • 醫療領域用巨量資料的急速成長
  • 阻礙市場要素
    • 對RWE研究的依賴的抗拒感
  • 課題
    • RWE開發缺乏標準的方法論
  • 市場機會
    • 新興國家
    • 端到端RWE服務的關注高漲
    • RWE的穿戴式設備、人工智慧的普及

第5章 法規分析

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他的國家 (RoW)

第6章 價格設定模式

  • 簡介
  • 每患者記錄的支付(以數量為準的價格設定)
  • 每使用量的支付(價值為基礎的價格設定)
  • 年度訂閱方式

第7章 全球RWE解決方案市場:各零件

  • 簡介
  • 資料集
    • 個別資料集
    • 一體型資料集
  • 服務

第8章 全球RWE解決方案市場:各用途

  • 簡介
  • 藥物的開發 (藥物研發)、核准
    • 腫瘤
    • 循環系統疾病
    • 神經症
    • 免疫疾病
    • 其他治療領域
  • 醫療設備的開發、核准
  • 市場進入,醫療費償付/保險補償範圍的決策
  • 臨床決策
  • 其他的用途

第9章 全球RWE解決方案市場:各終端用戶

  • 簡介
  • 製藥/生物科技/醫療設備企業
  • 付款者
  • 醫療提供者 (供應商)
  • 其他終端用戶

第10章 全球RWE解決方案市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他的歐洲各國
  • 亞太地區
    • 日本
    • 中國
    • 其他的亞太地區各國
  • 南美
  • 中東、非洲

第8章 競爭情形

  • 簡介
  • 主要的成長策略
  • 企業間比較分析
    • 分析方法
  • 市場佔有率分析 (2019年)

第12章 企業簡介

  • IQVIA Holdings Inc. (美國)
  • ICON plc (愛爾蘭)
  • Parexel International Corporation (美國)
  • PPD Inc. (美國)
  • International Business Machines Corporation (美國)
  • UnitedHealth Group Incorporated (美國)
  • Oracle Corporation (美國)
  • SAS Institute Inc. (美國)
  • Anthem Inc. (美國)
  • Clinigen Group plc (英國)
  • Cognizant Technology Solutions (CTS) Corporation
  • PerkinElmer, Inc. (美國)

第13章 附錄

目錄

Real-World Evidence (RWE) Solutions Market by Component [Datasets, EMR, Services], Application [Drug Development & Approvals (Oncology, Neurology, Immunology), Market Access, Medical Device Development], End User - Forecast to 2027

The real-world evidence solutions market is expected to grow at a CAGR of 16.5% from 2020 to 2027 to reach USD 3.13 billion by 2027.

Succeeding an extensive secondary and primary research and in-depth analysis of the market scenario, the report carries out the key industry drivers, restraints, challenges, and opportunities. The growth in the real-world evidence solutions market is mainly attributed to the rising geriatric population and burden of chronic diseases, the shift towards value-based care, growing focus on personalized healthcare, delays in drug development and the subsequent increase in development costs, and expanding use of RWE for regulatory decision making. Moreover, growth opportunities in emerging markets; rising focus on end-to-end RWE services; and emerging roles of wearable devices, social media, and AI in RWE provide growth opportunities for players operating in the real-world evidence solutions market.

Based on component, in 2020, the datasets segment is expected to account for the largest share due to the increasing need for additional insights on epidemiology; compliance, adherence, and costs in a realistic environment; rise in demand for information by the payers, regulatory bodies, and providers with regards to drug safety; growing amount of medical data generated in hospitals and healthcare facilities; and increasing dependence on outcome-based studies on real-world data.

Based on application, the drug development and approvals segment is estimated to account for the largest share of the market in 2020. An increase in the demand of RWD and RWE to accelerate drug discovery & development, increasing investment by biopharmaceutical companies in R&D, and growing inclination of regulatory bodies towards RWE are expected to propel the growth of this segment.

In terms of end-users of real-world evidence solutions, pharmaceutical, biotech & medical device companies tend to use them extensively. The increasing importance of RWE studies in drug development and approvals, growing focus to avoid costly drug recalls, and the increasing need to assess drug performance in real-world settings are the factors driving this end-user segment.

An in-depth analysis of the real-world evidence solutions market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. North America is estimated to account for the largest share of the real-world evidence solutions market in 2020, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa.

The key players operating in the real-world evidence solutions market are Anthem, Inc. (U.S.), Clinigen Group plc (U.K.), Cognizant Technology Solutions Corporation (U.S.), IBM Corporation (U.S.), ICON plc (Ireland), IQVIA (U.S.), Optum (A Subsidiary of United Health Group, Inc.) (U.S.), Oracle Corporation (U.S.), PAREXEL International Corporation (U.S.), PerkinElmer, Inc. (U.S.), PPD Inc., (U.S.), SAS Institute Inc. (U.S.), and Syneos Health, Inc. (U.S.), among others.

Scope of the Report:

Real-world Evidence Solutions Market, by Component

  • Datasets
  • Disparate Datasets
  • EMR/EHR/Clinical data
  • Claims & Billing Data
  • Pharmacy Data
  • Product/Disease Registries Data
  • Other Disparate Datasets
  • Integrated Datasets
  • Services

Other disparate datasets comprise data gathered from other sources that can inform health statuses, such as mobile devices, wearable devices, and social media.

Real-world Evidence Solutions Market, by Application

  • Drug Development & Approvals
  • Oncology
  • Cardiovascular Disease
  • Neurology
  • Immunology
  • Others Therapeutic Areas

Other therapeutic areas comprise infectious diseases, musculoskeletal disorders, dermatological diseases, and respiratory diseases.

  • Medical Device Development & Approvals
  • Market Access & Reimbursement/Coverage Decisions
  • Clinical Decision-Making
  • Other Applications

Other applications comprise regulatory decision-making, post-approval monitoring, and post-market device surveillance.

Real-world Evidence Solutions Market, by End User

  • Pharmaceutical, Biotechnology & Medical Device Companies
  • Healthcare Payers
  • Healthcare Providers
  • Other End Users

Other end-users comprise academic research institutions, patient advocacy groups, regulators, and health technology assessment agencies.

Real-world Evidence Solutions Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
  • Japan
  • China
  • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-Up Approach
      • 2.3.1.2. Top-Down Approach
      • 2.3.1.3. Growth Forecast
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for the Study
  • 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Introduction
  • 4.2. Drivers
    • 4.2.1. Growing Burden of Chronic Diseases in Geriatric Population
    • 4.2.2. Delays in Drug Development and the Subsequent Increase in Development Costs
    • 4.2.3. Rising Focus Towards Personalized Healthcare
    • 4.2.4. Shift Towards Value-Based Care
    • 4.2.5. Impact Assessment of COVID-19
    • 4.2.6. Rapidly Growing Big Data in Healthcare
  • 4.3. Restraints
    • 4.3.1. Reluctance to Rely on Real-World Studies
  • 4.4. Challenges
    • 4.4.1. Lack of Standardized Methodologies to Develop RWE
  • 4.5. Opportunities
    • 4.5.1. Emerging Economies
    • 4.5.2. Rising Focus on End-to-End RWE Services
    • 4.5.3. Rising Adoption of Wearable Devices and Artificial Intelligence in RWE

5. Regulatory Analysis

  • 5.1. Introduction
  • 5.2. North America
  • 5.3. Europe
  • 5.4. Asia-Pacific
  • 5.5. Rest of the World

6. Pricing Models

  • 6.1. Introduction
  • 6.2. Pay Per Patient Record (Volume-Based Pricing)
  • 6.3. Pay Per Usage (Value-Based Pricing)
  • 6.4. Annual Subscription

7. Global Real-World Evidence Solutions Market, by Component

  • 7.1. Introduction
  • 7.2. Datasets
    • 7.2.1. Disparate Datasets
      • 7.2.1.1. EMR/EHR/Clinical Data
      • 7.2.1.2. Claims & Billing Data
      • 7.2.1.3. Pharmacy Data
      • 7.2.1.4. Product/Disease Registries Data
      • 7.2.1.5. Others
    • 7.2.2. Integrated Datasets
  • 7.3 Services

8. Global Real-World Evidence Solutions Market, by Application

  • 8.1. Introduction
  • 8.2. Drug Development & Approvals
    • 8.2.1 Oncology
    • 8.2.2 Cardiovascular Disease
    • 8.2.3 Neurology
    • 8.2.4 Immunology
    • 8.2.5 Others Therapeutic Areas
  • 8.3. Medical Device Development & Approvals
  • 8.4. Market Access & Reimbursement/Coverage Decisions
  • 8.5. Clinical Decision-Making
  • 8.6. Other Applications

9. Global Real-World Evidence Solutions Market, by End User

  • 9.1. Introduction
  • 9.2. Pharmaceutical, Biotechnology & Medical Device Companies
  • 9.3. Healthcare Payers
  • 9.4. Healthcare Providers
  • 9.5. Other End Users

10. Global Real-World Evidence Solutions Market, by Geography

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
  • 10.3. Europe
    • 10.3.1. Germany
    • 10.3.2. France
    • 10.3.3. U.K.
    • 10.3.4. Italy
    • 10.3.5. Spain
    • 10.3.6. Rest of Europe
  • 10.4. Asia-Pacific
    • 10.4.1. Japan
    • 10.4.2. China
    • 10.4.3. Rest of Asia-Pacific
  • 10.5. Latin America
  • 10.6. Middle East & Africa

11. Competitive Landscape

  • 11.1. Introduction
  • 11.2. Key Growth Strategies
  • 11.3. Competitive Benchmarking
    • 11.3.1. Competitive Benchmarking, by Methodology
  • 11.4. Market Share Analysis (2019)

12. Company Profiles

  • 12.1. IQVIA Holdings Inc. (U.S.)
  • 12.2. ICON plc (Ireland)
  • 12.3. Parexel International Corporation (U.S.)
  • 12.4. PPD Inc. (U.S.)
  • 12.5. International Business Machines Corporation (U.S.)
  • 12.6. UnitedHealth Group Incorporated (U.S.)
  • 12.7. Oracle Corporation (U.S.)
  • 12.8. SAS Institute Inc. (U.S.)
  • 12.9. Anthem Inc. (U.S.)
  • 12.10 Clinigen Group plc (U.K.)
  • 12.11 Cognizant Technology Solutions (CTS) Corporation
  • 12.12. PerkinElmer, Inc. (U.S.)

13. Appendix

  • 13.1. Questionnaire
  • 13.2. Available Customization

List of Tables

  • Table 1 Global Real-World Evidence Solutions Market Drivers: Impact Analysis (2020-2027)
  • Table 2 Global Real-World Evidence Solutions Market Restraints: Impact Analysis (2020-2027)
  • Table 3 Global Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 4 Global Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 5 Global Real-World Evidence Solutions Datasets Market Size, by Country/Region 2018-2027 (USD Million)
  • Table 6 Global Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 7 Global Real-World Evidence Solutions Disparate Datasets Market Size, by Country/Region, 2018-2027 (USD Million)
  • Table 8 Global EMR/EHR/Clinical Datasets Market Size for RWE Solutions by Country/Region, 2018-2027 (USD Million)
  • Table 9 Global Claims & Billing Data Market Size for RWE Solutions by Country/Region, 2018-2027 (USD Million)
  • Table 10 Global Pharmacy Data Market Size for RWE Solutions by Country/Region, 2018-2027 (USD Million)
  • Table 11 Global Product/Disease Registries Data Market Size for RWE Solutions by Country/Region, 2018-2027 (USD Million)
  • Table 12 Global Other Disparate Datasets Market Size for RWE Solutions by Country/Region, 2018-2027 (USD Million)
  • Table 13 Global Real-World Evidence Solutions Integrated Datasets Market Size, by Country/Region, 2018-2027 (USD Million)
  • Table 14 Global Services Market Size for RWE Solutions by Country/Region, 2018-2027 (USD Million)
  • Table 15 Global Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 16 Global RWE Solutions Market Size for Drug Development & Approvals, by Therapeutic Area, 2018-2027 (USD Million)
  • Table 17 Global RWE Solutions Market Size for Drug Development & Approvals, by Country/Region, 2018-2027 (USD Million)
  • Table 18 Global RWE Solutions Market Size for Oncological Drug Development & Approvals, by Country/Region, 2018-2027 (USD Million)
  • Table 19 Global RWE Solutions Market Size for Cardiovascular Drug Development & Approvals, by Country/Region, 2018-2027 (USD Million)
  • Table 20 Global RWE Solutions Market Size for Neurology Drug Development & Approvals, by Country/Region, 2018-2027 (USD Million)
  • Table 21 Global RWE Solutions Market Size for Immunology Drug Development & Approvals, by Country/Region, 2018-2027 (USD Million)
  • Table 22 Global RWE Solutions Market Size for Other Therapeutic Areas Drug Development & Approvals, by Country/Region, 2018-2027 (USD Million)
  • Table 23 Global RWE Solutions Market Size for Market Access & Reimbursement/Coverage Decisions, by Country/Region, 2018-2027 (USD Million)
  • Table 24 Global RWE Solutions Market Size for Clinical Decision Making, by Country/Region, 2018-2027 (USD Million)
  • Table 25 Global RWE Solutions Market Size for Medical Device Development & Approvals, by Country/Region, 2018-2027 (USD Million)
  • Table 26 Global RWE Solutions Market Size for Other Applications, by Country/Region, 2018-2027 (USD Million)
  • Table 27 Global Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 28 Global Real-World Evidence Solutions Market Size, for Pharmaceutical, Biotechnology, and Medical Device Companies, by Country/Region, 2018-2027 (USD Million)
  • Table 29 Global Real-World Evidence Solutions Market Size, for Healthcare Payers, by Country/Region, 2018-2027 (USD Million)
  • Table 30 Global Real-World Evidence Solutions Market Size, for Healthcare Providers, by Country/Region, 2018-2027 (USD Million)
  • Table 31 Global Real-World Evidence Solutions Market Size, for Other End Users, by Country/Region, 2018-2027 (USD Million)
  • Table 32 Global Real-World Evidence Solutions Market Size, by Country/Region, 2018-2027 (USD Million)
  • Table 33 North America: Real-World Evidence Solutions Market Size, by Country, 2018-2027 (USD Million)
  • Table 34 North America: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 35 North America: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 36 North America: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 37 North America: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 38 North America: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 39 U.S.: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 40 U.S.: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 41 U.S.: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 42 U.S.: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 43 U.S.: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 44 Canada: Real -World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 45 Canada: Real -World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 46 Canada: Real -World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 47 Canada: Real -World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 48 Canada: Real -World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 49 European: Real-World Evidence Solutions Market Size, by Country, 2018-2027 (USD Million)
  • Table 50 European: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 51 European: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 52 European: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 53 European: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 54 European: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 55 Germany: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 56 Germany: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 57 Germany: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 58 Germany: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 59 Germany: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 60 U.K.: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 61 U.K.: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 62 U.K.: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 63 U.K.: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 64 U.K.: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 65 France: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 66 France: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 67 France: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 68 France: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 69 France: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 70 Italy: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 71 Italy: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 72 Italy: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 73 Italy: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 74 Italy: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 75 Spain: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 76 Spain: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 77 Spain: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 78 Spain: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 79 Spain: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 80 RoE: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 81 RoE: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 82 RoE: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 83 RoE: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 84 RoE: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 85 Asia-Pacific: Real-World Evidence Solutions Market Size, by Country, 2018-2027 (USD Million)
  • Table 86 Asia-Pacific: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 87 Asia-Pacific: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 88 Asia-Pacific: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 89 Asia-Pacific: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 90 Asia-Pacific: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 91 Japan: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 92 Japan: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 93 Japan: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 94 Japan: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 95 Japan: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 96 China: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 97 China: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 98 China: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 99 China: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 100 China: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 101 RoAPAC: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 102 RoAPAC: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 103 RoAPAC: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 104 RoAPAC: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 105 RoAPAC: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 106 Latin America: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 107 Latin America: Real-World Evidence Solutions Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 108 Latin America: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 109 Latin America: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 110 Latin America: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 111 Middle East & Africa: Real-World Evidence Solutions Market Size, by Component, 2018-2027 (USD Million)
  • Table 112 Middle East & Africa: Real-World Evidence Solutions Datasets Market Size, by Type, 2018- 2027 (USD Million)
  • Table 113 Middle East & Africa: Real-World Evidence Solutions Disparate Datasets Market Size, by Type, 2018-2027 (USD Million)
  • Table 114 Middle East & Africa: Real-World Evidence Solutions Market Size, by Application, 2018-2027 (USD Million)
  • Table 115 Middle East & Africa: Real-World Evidence Solutions Market Size, by End User, 2018-2027 (USD Million)
  • Table 116 Recent Developments, by Company, 2017-2020

List of Figures

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global Real-World Evidence Solutions Market Size, by Component, 2020 Vs. 2027 (USD Million)
  • Figure 8 Global Real-World Evidence Solutions Market Size, by Application, 2020 Vs. 2027 (USD Million)
  • Figure 9 Regional Snapshot: Real-World Evidence Solutions Market
  • Figure 10 Global Real-World Evidence Solutions Market Size, by Component, 2020-2027 (USD Million)
  • Figure 11 Global Real-World Evidence Solutions Market Size, by Application, 2020-2027 (USD Million)
  • Figure 12 Global Real-World Evidence Solutions Market Size, by End User, 2020-2027 (USD Million)
  • Figure 13 Global Real-World Evidence Solutions Market Size, by Country/Region, 2020-2027 (USD Million)
  • Figure 14 North America: Real-World Evidence Solutions Market Snapshot
  • Figure 15 Europe: Real-World Evidence Solutions Market Snapshot
  • Figure 16 Asia-Pacific: Real-World Evidence Solutions Market Snapshot
  • Figure 17 Key Growth Strategies Adopted by Leading Players, 2017-2020
  • Figure 18 Real-World Evidence Solutions Market: Competitive Benchmarking